Wednesday, October 05, 2016 8:21:39 AM
P2 didn't have the best results... BUT it was able to show what methods worked (if you find the slide show IMUC put together at the end of P2, it shows everything and how they're approaching P3 because of it).
The stock price has dwindled because investors are being impatient. This is not something that will happen overnight. Honestly, the longer that P3 takes, the better. The idea of this drug is to extend the lives of those with GBM, a 100% fatal cancer. If this can extend a life from 1 year to 3 years, it would be incredible, and it possibly can do such a thing.
Again, this will take time, but I believe it is completely worth buying into.
Recent IMUC News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/02/2023 07:11:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM